Analyzing COVID-19 mortality in Ernakulam district of Kerala: A retrospective review of death reports

被引:0
|
作者
Rohini, C. [1 ]
Kuriakose, Serin [1 ]
Philip, Shoba [2 ,3 ]
Sreedevi, S. [4 ]
机构
[1] Kerala Govt Hlth Serv, Dist Surveillance Unit, Kochi, Kerala, India
[2] Lourdes Hosp, Dept Crit Care, Kochi, Kerala, India
[3] Postgrad Inst Med Sci & Res, Kochi, Kerala, India
[4] Kerala Govt Hlth Serv, Thiruvananthapuram, Kerala, India
关键词
COVID-19; mortality; Ernakulam district; FATALITY RATES; DISEASES; INSIGHTS;
D O I
10.4103/jfmpc.jfmpc_648_22
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: COVID19 pandemic caused considerable mortality and had a huge impact on the health system and the world economy. In this context, it is important to characterize the demographic and clinical features of the fatal cases and to have a basic understanding on the additional burden caused by COVID19 on the health care system. Methods: Mortality reports of 408 patients who were diagnosed with COVID-19 in Ernakulam district during the period of 28th March 2020 - the day which reported the first COVID19 death in the district- till 28 February 2021 were collected using a uniform reporting format prepared by the district COVID19 surveillance unit. Results: Out of the 408 fatal cases 260 (64%) were males. The mean age of the cases was 69 years (SD:12, IQR:16-102 years). 31% (n=124) of the patients were admitted to more than one facility for treatment before the death. The median duration between the documented date of onset of symptoms to death was 11 days (IQR:0-46). Mean duration between the onset of COVID19 suspected symptoms to the collection of samples for laboratory test was 3 days and the duration up to the admission to a treatment facility was 4.5 days. The median duration between the admission to a facility and death was 7 days (mean 10, SD:7) with a range 0 to 40 days. The mean duration of hospital stay was 10 days for females and 8.5 days for males. Most frequent symptom at presentation was breathlessness 50% (n=211), followed by fever 43% (n=179). 96% of the cases were reported to have any comorbidity and among those most common was Diabetes mellitus and stroke 60%, followed by Hypertension 54%. However, there was no significant difference in duration of hospital stay and survival period across age group, sex or number of comorbidities which may need further analysis. Conclusion: 6 out of 10 of the fatal cases were males and the mean age was 69 years, Though the mean age was similar for both sexes, median age was slightly higher for females. The proportion was found increasing as the age advanced. One third of the patients were admitted and treated at more than one facility and moreover 6 out of 10 utilized government facilities for treatment. Median duration of survival was 11 days while the median duration of hospital stay was 10 days. Symptomatology was found similar to cases reported worldwide. More than 9 out of 10 had reported at least one comorbidity and the most frequent comorbidities reported were Diabetes mellitus and Cerebrovascular accident. Most frequently observed combination was of a triad of Hypertension-Diabetes-Stroke. This data is of prime importance as Kerala is at an advanced level of epidemiological transition and demographic transition compared to other Indian states and emerging infections like COVI19 could be a double burden to the community.
引用
收藏
页码:6209 / 6214
页数:6
相关论文
共 50 条
  • [21] Mortality in mechanically ventilated patients with COVID-19: a systematic review
    Vafea, Maria Tsikala
    Zhang, Raina
    Kalligeros, Markos
    Mylona, Evangelia K.
    Shehadeh, Fadi
    Mylonakis, Eleftherios
    EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (05) : 457 - 471
  • [22] Kerala's Response to COVID-19
    Sadanandan, Rajeev
    INDIAN JOURNAL OF PUBLIC HEALTH, 2020, 64 : 99 - 101
  • [23] Mortality and survival of COVID-19
    Sousa, G. J. B.
    Garces, T. S.
    Cestari, V. R. F.
    Florencio, R. S.
    Moreira, T. M. M.
    Pereira, M. L. D.
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [24] Mortality from COVID-19
    Franchini, M.
    Bongiovanni, G.
    Cruciani, M.
    ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2021, 33 (05): : 521 - 523
  • [25] COVID-19 Mortality in Pediatrics
    Hossaini, Kamal Eshagh
    Hormati, Ahmad
    Heydari, Hosein
    Ghadir, Mohammad Reza
    Afifian, Mahboubeh
    Ahmadpour, Sajjad
    IRANIAN JOURNAL OF PEDIATRICS, 2021, 31 (03)
  • [26] COVID-19 and mortality in doctors
    Iyengar, Karthikeyan P.
    Ish, Pranav
    Upadhyaya, Gaurav Kumar
    Malhotra, Nipun
    Vaishya, Raju
    Jain, Vijay Kumar
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) : 1743 - 1746
  • [27] Excess of mortality and mortality from COVID-19 and other causes of death in 2020 in Navarra, Spain
    Moreno-Iribas, Conchi
    Floristan, Yugo
    Iniesta, Irene
    Ardanaz, Eva
    Guevara, Marcela
    Delfrade, Josu
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2022, 45 (03)
  • [28] On Analyzing Capnogram as a Novel Method for Screening COVID-19: A Review on Assessment Methods for COVID-19
    Malarvili, M. B.
    Alexie, Mushikiwabeza
    Dahari, Nadhira
    Kamarudin, Anhar
    LIFE-BASEL, 2021, 11 (10):
  • [29] Clinical Mortality Review of COVID-19 Patients at Sukraraj Tropical and Infectious Disease Hospital, Nepal; A Retrospective Study
    Bastola, Anup
    Shrestha, Sanjay
    Nepal, Richa
    Maharjan, Kijan
    Shrestha, Bikesh
    Chalise, Bimal Sharma
    Thapa, Pratistha
    Balla, Pujan
    Sapkota, Alisha
    Shah, Priyanka
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2021, 6 (03)
  • [30] Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review
    Zeraatkar, Dena
    Pitre, Tyler
    Leung, Gareth
    Cusano, Ellen
    Agarwal, Arnav
    Khalid, Faran
    Escamilla, Zaira
    Cooper, Matthew Adam
    Ghadimi, Maryam
    Wang, Ying
    Verdugo-Paiva, Francisca
    Rada, Gabriel
    Kum, Elena
    Qasim, Anila
    Bartoszko, Jessica Julia
    Siemieniuk, Reed Alexander Cunningham
    Patel, Chirag
    Guyatt, Gordon
    Brignardello-Petersen, Romina
    BMJ MEDICINE, 2022, 1 (01):